We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




POC PCR Test Rapidly Detects Bacterial Meningitis Directly at Point of Sample Collection

By LabMedica International staff writers
Posted on 13 Jan 2025
Print article
Image: The test covers the most important bacterial pathogens across all age groups with a single cartridge (Photo courtesy of BHCS)
Image: The test covers the most important bacterial pathogens across all age groups with a single cartridge (Photo courtesy of BHCS)

Meningitis is an inflammation of the membranes surrounding the brain and spinal cord. Pathogens typically enter the body through the respiratory tract and spread via the bloodstream. The infection can also be transmitted from nearby structures, such as in cases of middle ear or paranasal sinus inflammation. Every year, 2.5 million people are affected globally, with the majority living in poorer regions. More than half of these cases occur in children under the age of five. Common symptoms include headaches, difficulty concentrating, fever, and a stiff neck. The pathogens responsible for meningitis can be bacteria, viruses, fungi, or parasites. However, bacterial meningitis is especially concerning, with one in five cases leading to permanent complications like hearing loss, brain damage, and seizures. Without prompt treatment, approximately half of those affected may die. Rapid and reliable pathogen detection is essential to reduce the high morbidity and mortality rates by enabling timely and targeted antibiotic treatment. Now, a new PCR rapid test can specifically identify the six most common causes of bacterial meningitis in under an hour.

Bosch Healthcare Solutions (BHCS, Waiblingen, Germany;) has developed the Vivalytic Bacterial Meningitis PCR test for its Vivalytic analysis platform. This test can identify six major bacterial pathogens responsible for meningitis in less than an hour, using highly sensitive PCR technology. According to current guidelines for adults, antibiotic treatment should begin within one to three hours of a patient’s arrival at the emergency room. The Vivalytic Bacterial Meningitis test, using cerebrospinal fluid (CSF), provides reliable results within this crucial timeframe. The test can detect Neisseria meningitidis, Streptococcus pneumoniae, Haemophilus influenzae, Streptococcus agalactiae, Escherichia coli, and Listeria monocytogenes, covering the most significant bacterial pathogens across all age groups on a single cartridge. Newborns and young infants are particularly vulnerable to infections caused by Streptococcus agalactiae, Escherichia coli, and Listeria monocytogenes. Older infants, toddlers, and young adults are at risk from Neisseria meningitidis and Streptococcus pneumoniae. In older adults, Streptococcus pneumoniae is more commonly implicated. Guidelines for testing antibiotic susceptibility suggest that PCR tests should be complemented by a CSF culture. After collecting CSF, it is recommended to start antibiotic treatment immediately, possibly alongside dexamethasone.

The Vivalytic system is user-friendly and requires only brief training for medical staff. The collected sample is placed into a test cartridge, which contains all the necessary reagents. The cartridge is then inserted into the Vivalytic Analyzer for automated processing. The test result is displayed in under an hour. The fully automated workflow of the all-in-one platform reduces the risk of infection for the user. The Vivalytic Bacterial Meningitis test allows for reliable and straightforward diagnostics, even during off-peak hours, such as weekends and evenings. While traditional PCR tests take a full day in the laboratory and culture confirmation requires two days, the Bosch test delivers results in under an hour. BHCS has recently received CE certification for the Vivalytic Bacterial Meningitis test. The World Health Organization (WHO) aims to eliminate bacterial meningitis worldwide by 2030, including the eradication of meningitis epidemics.

“Rapid diagnosis using multiplex PCR tests could play a crucial role in this,” said Marc Meier, president of Bosch Healthcare Solutions.

Related Links:
BHCS

Gold Member
Troponin T QC
Troponin T Quality Control
New
Gold Member
Pharmacogenetics Panel
VeriDose Core Panel v2.0
New
Chagas Disease Test
Simple/Stick Chagas/WB
New
Gold Member
Strep Pneumoniae Rapid Test
Strep Pneumoniae (6503 – 6573)

Print article

Channels

Molecular Diagnostics

view channel
Image: The kit includes a container with a film, a compact optical device for attaching a smartphone, and a diagnostic app (Photo courtesy of KIST)

Urine-Based Bladder Cancer Diagnostic Kit to Reduce Need for Unnecessary Cystoscopies

Bladder cancer has a high cure rate of over 90% when detected early, but it is characterized by a recurrence rate of 70%, which requires continuous monitoring. Late-stage detection often results in major... Read more

Pathology

view channel
Image: The AI tool can search through data and histology images for much more precise information on cancer treatment effectiveness (Photo courtesy of Shutterstock)

AI Tool Analyzes 30K Data Points Per Medical Imaging Pixel in Cancer Search

A new artificial intelligence (AI)-powered tool can detect cell-level characteristics of cancer by analyzing data from very small tissue samples, some as tiny as 400 square micrometers, equivalent to the... Read more

Technology

view channel
Image: Human tear film protein sampling methods (Photo courtesy of Clinical Proteomics. 2024 Mar 13;21:23. doi: 10.1186/s12014-024-09475-8)

New Lens Method Analyzes Tears for Early Disease Detection

Bodily fluids, including tears and saliva, carry proteins that are released from different parts of the body. The presence of specific proteins in these biofluids can be a sign of health issues.... Read more

Industry

view channel
Image: The game-changing immunoassay diagnostics platform delivers results from whole blood sample in 10 minutes (Photo courtesy of SpinChip)

bioMérieux Acquires Norwegian Immunoassay Start-Up SpinChip Diagnostics

bioMérieux (Marcy l’Étoile, France) has agreed to acquire SpinChip Diagnostics (Oslo, Norway), the developer of a game-changing immunoassay diagnostics platform. The small benchtop analyzer is well adapted... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.